Changes in bioactive and immunoactive inhibin levels around human labor

Area of Science:

• Reproductive Endocrinology
• Maternal-Fetal Medicine
• Biochemistry

Background:

• Inhibins (bioinhibin and immunoinhibin) play crucial roles in reproductive physiology.
• Understanding inhibin dynamics during pregnancy and postpartum is essential for reproductive health research.

Purpose of the Study:

• To investigate the changes in maternal serum bioinhibin (B-inhibin) and immunoinhibin (I-inhibin) levels before and after delivery.
• To compare inhibin levels in maternal serum, retroplacental serum, umbilical cord serum, amniotic fluid, and placental extract.

Main Methods:

• Ovine pituitary cell culture and immunoenzymatic assays were used to quantify B-inhibin and I-inhibin.
• Serum, amniotic fluid, and placental tissue samples were collected from healthy term pregnant women.
• Levels were measured before and at various time points after delivery (30 min, 1 h, 6 h, 24 h).

Main Results:

• Maternal serum B-inhibin and I-inhibin levels declined sharply within 6 hours postpartum, reaching near-undetectable levels by 24 hours.
• Retroplacental serum and amniotic fluid showed significantly higher I-inhibin levels compared to maternal serum before delivery.
• Placental extract exhibited the highest concentrations of both B-inhibin and I-inhibin, with I-inhibin being more than twice as abundant as B-inhibin.

Conclusions:

• The rapid decline in maternal serum inhibin levels post-delivery suggests a placental origin.
• Higher concentrations of inhibins in placental tissue, retroplacental serum, and amniotic fluid support the placenta as the main production site during pregnancy.
• These findings contribute to the understanding of inhibin's role and source in human pregnancy.